Dublin-based wholesale drug distribution and medical supplies company Cardinal Health is spending $3.9 billion on two ...

Drug distributor Cardinal Health said on Monday it will take a majority stake in gastroenterology care platform GI Alliance ...

The drug distributor will buy a majority stake in gastroenterology practice management group GI Alliance and purchase ...

Cardinal Health plans acquisitions to anchor its new territory managing specialty physician groups and expand its home-care ...

A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.

Cardinal Health plans to buy two companies that will expand its diabetes and gastroenterology businesses as part of an ...

From energy to healthcare, here's a list of other key deals this week:  Exxon Mobil (NYSE:XOM) has reportedly agreed to ...

Cardinal Health’s planned acquisition of Advanced Diabetes Supply Group for $1.1 billion marries its logistics and ...

The healthcare products and services company plans to acquire Advanced Diabetes Supply Group and a majority stake in GI ...

Cardinal will acquire a majority stake in GIA, a gastroenterology (GI) management services organization (MSO), from a ...

Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds.

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on Cardinal Health (CAH – Research Report). The associated price target remains the same with $127.00. Erin Wright has given his ...